New England Clinical Research is categorized under Commercial Nonphysical Research in Ridgefield, CT and active since 1997.
New England Clinical Research was established in 1997, and today employs 1 to 4, earning Unknown per year. This is a Commercial Nonphysical Research business, which does work in the B2B market, and is classified as a Commercial Nonphysical Research, under code number 5419100 by the NAICS.
If you are seeking more information, feel free to contact Karen Houck at the company’s single location by writing to 17 Laurel Hill Road, Ridgefield, Connecticut CT 06877 or by phoning (203) 544-8093. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | New England Clinical Research |
| Contact Person: | Karen Houck |
| Address: | 17 Laurel Hill Road, Ridgefield, Connecticut 06877 |
| Phone Number: | (203) 544-8093 |
| Annual Revenue (USD): | Unknown |
| Founded: | 1997 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Nonphysical Research |
| SIC Code: | 8732 |
| NAICS Code: | 5419100 |
| Share This Business: |
New England Clinical Research was started in 1997 to provide professional Commercial Nonphysical Research under the SIC code 8732 and NAICS code 5419100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Karen Houck for inquiries that concern New England Clinical Research by calling the company number (203) 544-8093, as your correspondence is most welcome. Additionally, the physical location of the single location of New England Clinical Research can be found at the coordinates 41.275665,-73.449392 as well as the street address 17 Laurel Hill Road in Ridgefield, Connecticut 06877.
For its online presence, you may visit New England Clinical Research’s website at and engage with its social media outlets through on Twitter and on Facebook.